Vishnu C. Ramani

3.3k total citations · 1 hit paper
31 papers, 2.6k citations indexed

About

Vishnu C. Ramani is a scholar working on Molecular Biology, Cell Biology and Hematology. According to data from OpenAlex, Vishnu C. Ramani has authored 31 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cell Biology and 14 papers in Hematology. Recurrent topics in Vishnu C. Ramani's work include Proteoglycans and glycosaminoglycans research (14 papers), Multiple Myeloma Research and Treatments (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Vishnu C. Ramani is often cited by papers focused on Proteoglycans and glycosaminoglycans research (14 papers), Multiple Myeloma Research and Treatments (10 papers) and Glycosylation and Glycoproteins Research (8 papers). Vishnu C. Ramani collaborates with scholars based in United States, Switzerland and Israel. Vishnu C. Ramani's co-authors include Ralph D. Sanderson, Stefanie S. Jeffrey, Meghaan M. Ferreira, Israël Vlodavsky, Anurag Purushothaman, Randy S. Haun, Yongsheng Ren, Leah Hennings, Mark Stewart and Sadie Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Vishnu C. Ramani

28 papers receiving 2.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating tumor cell technologies

2016 409 citations Meghaan M. Ferreira, Vishnu C. Ramani et al. Molecular Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vishnu C. Ramani United States	23	1.5k	868	853	850	290	31	2.6k
Chris D. Madsen Sweden	19	1.1k 0.7×	1.0k 1.2×	672 0.8×	666 0.8×	358 1.2×	33	2.6k
Stephen J. Weiss United States	11	856 0.6×	952 1.1×	456 0.5×	1.3k 1.5×	164 0.6×	12	2.3k
Sadie Aznavoorian United States	13	1.1k 0.8×	960 1.1×	581 0.7×	1.0k 1.2×	127 0.4×	16	2.6k
Alicia Viloria‐Petit Canada	23	2.4k 1.7×	1.4k 1.6×	358 0.4×	1.3k 1.6×	182 0.6×	48	3.8k
H. Michael Shepard United States	18	1.1k 0.8×	1.8k 2.0×	667 0.8×	516 0.6×	383 1.3×	40	2.9k
Hikaru Sonoda Japan	21	2.4k 1.6×	387 0.4×	216 0.3×	1.2k 1.4×	208 0.7×	37	2.9k
Paola Spessotto Italy	31	1.1k 0.8×	734 0.8×	412 0.5×	449 0.5×	65 0.2×	85	2.6k
Michael D. Oberst Germany	29	1.1k 0.7×	473 0.5×	260 0.3×	380 0.4×	82 0.3×	77	2.7k
Alexander Berndt Germany	35	1.7k 1.1×	1.3k 1.5×	428 0.5×	656 0.8×	169 0.6×	137	4.1k
Charlotte Morrison Canada	23	1.0k 0.7×	919 1.1×	253 0.3×	1.2k 1.4×	56 0.2×	30	2.4k

Countries citing papers authored by Vishnu C. Ramani

Since Specialization

Citations

This map shows the geographic impact of Vishnu C. Ramani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishnu C. Ramani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishnu C. Ramani more than expected).

Fields of papers citing papers by Vishnu C. Ramani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishnu C. Ramani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishnu C. Ramani. The network helps show where Vishnu C. Ramani may publish in the future.

Co-authorship network of co-authors of Vishnu C. Ramani

This figure shows the co-authorship network connecting the top 25 collaborators of Vishnu C. Ramani. A scholar is included among the top collaborators of Vishnu C. Ramani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishnu C. Ramani. Vishnu C. Ramani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, Christopher L., Ashwin Sachdeva, Diego F. Sánchez, et al.. (2024). Hypoxia Detection in Prostate Cancer with Oxygen-Enhanced BOLD MRI. International Journal of Radiation Oncology*Biology*Physics. 120(2). S160–S161.

Vences‐Catalán, Felipe, Ranjani Rajapaksa, Chiung-Chi Kuo, et al.. (2021). Targeting the tetraspanin CD81 reduces cancer invasion and metastasis. Proceedings of the National Academy of Sciences. 118(24). 41 indexed citations

Sollier, Elodie, Sam W. Baker, Alex McMillan, et al.. (2020). Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer. Clinical & Experimental Metastasis. 37(3). 413–424. 11 indexed citations

Tripathi, Kaushlendra, Vishnu C. Ramani, Shyam Bandari, et al.. (2019). Heparanase promotes myeloma stemness and in vivo tumorigenesis. Matrix Biology. 88. 53–68. 33 indexed citations

Ramani, Vishnu C., Kuo‐Wei Huang, James Che, et al.. (2018). Fast and Label-Free Isolation of Circulating Tumor Cells from Blood: From a Research Microfluidic Platform to an Automated Fluidic Instrument, VTX-1 Liquid Biopsy System. SLAS TECHNOLOGY. 23(1). 16–29. 47 indexed citations

Ramani, Vishnu C., Rakhi Gupta, Gerald Quon, et al.. (2017). Abstract 1847: Evaluating the metastatic potential and the molecular heterogeneity of patient-derived orthotopic xenograft models of triple-negative breast cancer. Cancer Research. 77(13_Supplement). 1847–1847. 1 indexed citations

Bandari, Shyam, Anurag Purushothaman, Vishnu C. Ramani, et al.. (2017). Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biology. 65. 104–118. 188 indexed citations

Ferreira, Meghaan M., Vishnu C. Ramani, & Stefanie S. Jeffrey. (2016). Circulating tumor cell technologies. Molecular Oncology. 10(3). 374–394. 409 indexed citations breakdown →

Ramani, Vishnu C., Israël Vlodavsky, Yi Zhang, et al.. (2016). Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype. Matrix Biology. 55. 22–34. 76 indexed citations

10.

Ramani, Vishnu C., Fenghuang Zhan, Jianbo He, et al.. (2015). Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma. Oncotarget. 7(2). 1598–1607. 79 indexed citations

11.

Stewart, Mark, Vishnu C. Ramani, & Ralph D. Sanderson. (2014). Shed Syndecan-1 Translocates to the Nucleus of Cells Delivering Growth Factors and Inhibiting Histone Acetylation. Journal of Biological Chemistry. 290(2). 941–949. 50 indexed citations

12.

Purushothaman, Anurag, et al.. (2013). Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes. Journal of Biological Chemistry. 288(14). 10093–10099. 282 indexed citations

13.

Ramani, Vishnu C. & Ralph D. Sanderson. (2013). Chemotherapy stimulates syndecan-1 shedding: A potentially negative effect of treatment that may promote tumor relapse. Matrix Biology. 35. 215–222. 54 indexed citations

14.

Ramani, Vishnu C., et al.. (2012). Heparan Sulfate Chains of Syndecan-1 Regulate Ectodomain Shedding. Journal of Biological Chemistry. 287(13). 9952–9961. 105 indexed citations

15.

Ramani, Vishnu C., Yongsheng Ren, Annamaria Naggi, et al.. (2011). SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis. Clinical Cancer Research. 17(6). 1382–1393. 209 indexed citations

16.

Yang, Yang, Yongsheng Ren, Vishnu C. Ramani, et al.. (2010). Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL. Cancer Research. 70(21). 8329–8338. 56 indexed citations

17.

Ramani, Vishnu C., Leah Hennings, & Randy S. Haun. (2008). Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. BMC Cancer. 8(1). 373–373. 55 indexed citations

18.

Ramani, Vishnu C. & Randy S. Haun. (2008). The extracellular matrix protein fibronectin is a substrate for kallikrein 7. Biochemical and Biophysical Research Communications. 369(4). 1169–1173. 41 indexed citations

19.

Ramani, Vishnu C. & Randy S. Haun. (2008). Expression of Kallikrein 7 Diminishes Pancreatic Cancer Cell Adhesion to Vitronectin and Enhances Urokinase-Type Plasminogen Activator Receptor Shedding. Pancreas. 37(4). 399–404. 21 indexed citations

20.

Johnson, Sadie, Vishnu C. Ramani, Leah Hennings, & Randy S. Haun. (2007). Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E‐cadherin. Cancer. 109(9). 1811–1820. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact